Literature DB >> 1361997

Theoretical and therapeutic considerations for the anxiety disorders.

L Taylor1, J Gorman.   

Abstract

Everyone is familiar with that paralyzing state of dread known as anxiety. Although it is unpleasant, the experience of anxiety has adaptive aspects: it can serve as an impetus to effect beneficial life change and can facilitate psychological development. Anxiety becomes of clinical concern, however, when it interferes with intellectual function, or arrests normal social or vocational pursuits. Anxiety disorders are chronic illnesses. Treatment can eliminate many of the disease's debilitating features, but the underlying disorder is not usually cured. Discontinuation of treatment-pharmacological, behavioral, or both-often results in the recurrence of symptoms. The focus of treatment, therefore, generally centers on striking a balance between the goal of alleviating the patient's symptoms, and the need to avoid the deleterious effects which result from long-term treatment (1). The intention of this paper is to review theoretical and therapeutic considerations for four types of anxiety disorder: panic disorder, generalized anxiety disorder, social phobia, and obsessive-compulsive disorder. In doing this, emphasis will be placed on the physiological concomitants and, when possible, neuropsychological bases of these illnesses. Furthermore, pharmacological treatment will be related to the underlying substrata of the disorder whenever possible.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1361997     DOI: 10.1007/bf01066762

Source DB:  PubMed          Journal:  Psychiatr Q        ISSN: 0033-2720


  74 in total

Review 1.  The waking nightmare: an overview of obsessive compulsive disorder.

Authors:  J L Rapoport
Journal:  J Clin Psychiatry       Date:  1990-11       Impact factor: 4.384

2.  A developmental-genetic analysis of common fears from early adolescence to early adulthood.

Authors:  R J Rose; W B Ditto
Journal:  Child Dev       Date:  1983-04

3.  Social skills training of out-patient groups. A controlled study of rehearsal and homework.

Authors:  I R Falloon; P Lindley; R McDonald; I M Marks
Journal:  Br J Psychiatry       Date:  1977-12       Impact factor: 9.319

4.  A comparison of lactate and isoproterenol anxiety states.

Authors:  J M Rainey; R B Pohl; M Williams; E Knitter; R R Freedman; E Ettedgui
Journal:  Psychopathology       Date:  1984       Impact factor: 1.944

5.  Genetic factors in anxiety disorders.

Authors:  S Torgersen
Journal:  Arch Gen Psychiatry       Date:  1983-10

6.  Clomipramine treatment of obsessive-compulsive disorder. I. A controlled clinical trial.

Authors:  P Thorén; M Asberg; B Cronholm; L Jörnestedt; L Träskman
Journal:  Arch Gen Psychiatry       Date:  1980-11

7.  A benzodiazepine receptor-mediated model of anxiety. Studies in nonhuman primates and clinical implications.

Authors:  T R Insel; P T Ninan; J Aloi; D C Jimerson; P Skolnick; S M Paul
Journal:  Arch Gen Psychiatry       Date:  1984-08

8.  Clinical characteristics and family history in DSM-III obsessive-compulsive disorder.

Authors:  S A Rasmussen; M T Tsuang
Journal:  Am J Psychiatry       Date:  1986-03       Impact factor: 18.112

Review 9.  Drug treatment of social phobia.

Authors:  J M Gorman; L K Gorman
Journal:  J Affect Disord       Date:  1987 Sep-Oct       Impact factor: 4.839

Review 10.  Benzodiazepine withdrawal: overview and implications for the treatment of anxiety.

Authors:  P P Roy-Byrne; D Hommer
Journal:  Am J Med       Date:  1988-06       Impact factor: 4.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.